Knockdown of P4HA1 has been reported to inhibit cancer cell proliferation in vitro and reduce tumor growth in xenograft models of breast and prostate cancer and gliomas (Chakravarthi et al., 2014; Gilkes et al., 2013b; Zhou et al., 2017). The gene discussed is P4HA1; the disease is cancer.